Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Does vaginal size impact sexual activity and function?
Schimpf MO, Harvie HS, Omotosho TB, Epstein LB, Jean-Michel M, Olivera CK, Rooney KE, Balgobin S, Ibeanu OA, Gala RB, Rogers RG; Society of Gynecologic Surgeons Fellows' Pelvic Research Network. Schimpf MO, et al. Int Urogynecol J. 2010 Apr;21(4):447-52. doi: 10.1007/s00192-009-1051-2. Epub 2009 Dec 4. Int Urogynecol J. 2010. PMID: 19960183 Free PMC article.
Sexual activity and function in women with and without pelvic floor disorders.
Fashokun TB, Harvie HS, Schimpf MO, Olivera CK, Epstein LB, Jean-Michel M, Rooney KE, Balgobin S, Ibeanu OA, Gala RB, Rogers RG; Society of Gynecologic Surgeons’ Fellows’ Pelvic Research Network. Fashokun TB, et al. Among authors: jean michel m. Int Urogynecol J. 2013 Jan;24(1):91-7. doi: 10.1007/s00192-012-1848-2. Epub 2012 Jun 29. Int Urogynecol J. 2013. PMID: 22744621 Free PMC article.
"Eyeball" POP-Q examination: shortcut or valid assessment tool?
Karp DR, Peterson TV, Jean-Michel M, Lefevre R, Davila GW, Aguilar VC. Karp DR, et al. Among authors: jean michel m. Int Urogynecol J. 2010 Aug;21(8):1005-9. doi: 10.1007/s00192-010-1139-8. Epub 2010 May 4. Int Urogynecol J. 2010. PMID: 20440479
Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (ANRS 12 300 Reflate TB 2): an open-label, non-inferiority, randomised, phase 3 trial.
De Castro N, Marcy O, Chazallon C, Messou E, Eholié S, N'takpe JB, Bhatt N, Khosa C, Timana Massango I, Laureillard D, Chau GD, Domergue A, Veloso V, Escada R, Wagner Cardoso S, Delaugerre C, Anglaret X, Molina JM, Grinsztejn B; ANRS 12300 Reflate TB2 study group. De Castro N, et al. Lancet Infect Dis. 2021 Jun;21(6):813-822. doi: 10.1016/S1473-3099(20)30869-0. Epub 2021 Mar 2. Lancet Infect Dis. 2021. PMID: 33667406 Clinical Trial.
12 results